{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:24:00Z","timestamp":1791246240061,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejmech.2023.116056","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:56:36Z","timestamp":1702727796000},"page":"116056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Plasmodium falciparum topoisomerases: Emerging targets for anti-malarial therapy"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9421-6141","authenticated-orcid":false,"given":"Ashraf","family":"Dar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Godara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaneswar","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masarat","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.116056_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40101-020-00251-9","article-title":"Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology","volume":"40","author":"Sato","year":"2021","journal-title":"J. Physiol. Anthropol."},{"key":"10.1016\/j.ejmech.2023.116056_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/1475-2875-9-320","article-title":"Determinants of delay in malaria treatment-seeking behaviour for under-five children in south-west Ethiopia: a case control study","volume":"9","author":"Getahun","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2023.116056_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1098\/rstb.2009.0273","article-title":"The evolution, metabolism and functions of the apicoplast","volume":"365","author":"Lim","year":"2010","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejmech.2023.116056_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (Mosquirix\u2122): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ejmech.2023.116056_bib5","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1098\/rstb.2011.0091","article-title":"Vaccines against malaria","volume":"366","author":"Hill","year":"2011","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejmech.2023.116056_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.668574","article-title":"Chloroquine and sulfadoxine-pyrimethamine resistance in sub-saharan Africa-A review","volume":"12","author":"Roux","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2023.116056_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in Plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2023.116056_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116056_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0092-8674(03)01023-7","article-title":"Plasmodium biology: genomic gleanings","volume":"115","author":"Aravind","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.116056_bib10","first-page":"1777","article-title":"DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery","volume":"277","author":"Garc\u00eda-Estrada","year":"2010","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.ejmech.2023.116056_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2023.116056_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib13","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212847","article-title":"A tale of topoisomerases and the knotty genetic material in the backdrop of Plasmodium biology","volume":"42","author":"Singh","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2023.116056_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bcp.2015.03.018","article-title":"Targeting the gyrase of Plasmodium falciparum with topoisomerase poisons","volume":"95","author":"Tang Girdwood","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116056_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrmicro1392","article-title":"Plasmodium post-genomics: better the bug you know?","volume":"4","author":"Kooij","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2023.116056_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-018-6127-9","article-title":"Plasmodium genomics: an approach for learning about and ending human malaria","volume":"118","author":"Garrido-Cardenas","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13071-018-2800-1","article-title":"Checks and balances? DNA replication and the cell cycle in Plasmodium","volume":"11","author":"Matthews","year":"2018","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2023.116056_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12551-016-0240-8","article-title":"The dynamic interplay between DNA topoisomerases and DNA topology","volume":"8","author":"Seol","year":"2016","journal-title":"Biophysical Reviews"},{"key":"10.1016\/j.ejmech.2023.116056_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202000286","article-title":"DNA topoisomerases: advances in understanding of cellular roles and multi-protein complexes via structure-function analysis","volume":"43","author":"McKie","year":"2021","journal-title":"Bioessays"},{"key":"10.1016\/j.ejmech.2023.116056_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12551-016-0240-8","article-title":"The dynamic interplay between DNA topoisomerases and DNA topology","volume":"8","author":"Seol","year":"2016","journal-title":"Biophys Rev"},{"key":"10.1016\/j.ejmech.2023.116056_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/EC.00357-06","article-title":"Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit","volume":"6","author":"Dar","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ejmech.2023.116056_bib22","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/EC.00149-09","article-title":"A unique 45-amino-acid region in the toprim domain of Plasmodium falciparum gyrase B is essential for its activity","volume":"8","author":"Dar","year":"2009","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ejmech.2023.116056_bib23","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.M115.639039","article-title":"Topoisomerase II from human malaria parasites: expression, purification, and selective inhibition","volume":"290","author":"Mudeppa","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00025-15","article-title":"Radicicol-mediated inhibition of topoisomerase VIB-VIA activity of the human malaria parasite Plasmodium falciparum","volume":"1","author":"Chalapareddy","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.ejmech.2023.116056_bib25","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/nar\/22.13.2547","article-title":"The gene encoding topoisomerase II from Plasmodium falciparum","volume":"22","author":"Cheesman","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","article-title":"Human topoisomerases and their roles in genome stability and organization","volume":"23","author":"Pommier","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib27","series-title":"Encyclopedia of Biological Chemistry","first-page":"157","article-title":"DNA topoisomerases: type I","author":"Champoux","year":"2013"},{"key":"10.1016\/j.ejmech.2023.116056_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/nar\/gkn1009","article-title":"Structural studies of type I topoisomerases","volume":"37","author":"Baker","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib29","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.3390\/molecules25204769","article-title":"Mechanism of type IA topoisomerases","volume":"25","author":"Dasgupta","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.116056_bib30","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1093\/nar\/gkn460","article-title":"Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region","volume":"36","author":"Sorokin","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib31","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/nar\/gkq1284","article-title":"ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism","volume":"39","author":"Sengupta","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib32","series-title":"Encyclopedia of Biological Chemistry","first-page":"806","article-title":"DNA topoisomerases: type II","author":"V\u00e9lez-Cruz","year":"2004"},{"key":"10.1016\/j.ejmech.2023.116056_bib33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/nar\/gkn937","article-title":"The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing","volume":"37","author":"Deweese","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib34","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1093\/nar\/gkt828","article-title":"On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs","volume":"41","author":"Wu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib35","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1093\/nar\/gku568","article-title":"DNA topoisomerase VIII: a novel subfamily of type IIB topoisomerases encoded by free or integrated plasmids in Archaea and Bacteria","volume":"42","author":"Gadelle","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib36","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.jmb.2019.07.008","article-title":"DNA topoisomerase inhibitors: Trapping a DNA-cleaving machine in Motion","volume":"431","author":"Bax","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mrfmmm.2007.06.009","article-title":"DNA topoisomerase II, genotoxicity, and cancer","volume":"623","author":"McClendon","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib38","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1073\/pnas.132378799","article-title":"The mechanism of type IA topoisomerases","volume":"99","author":"Dekker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.116056_bib39","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1042\/BCJ20200318","article-title":"Elucidation of an essential function of the unique charged domain of Plasmodium topoisomerase III","volume":"477","author":"Bansod","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2023.116056_bib40","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1093\/nar\/gku803","article-title":"Multifaceted role of the Topo III\u03b1\u2013RMI1-RMI2 complex and DNA2 in the BLM-dependent pathway of DNA break end resection","volume":"42","author":"Daley","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2023.116056_bib42","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1073\/pnas.1100300108","article-title":"Crystal structure of a covalent intermediate in DNA cleavage and rejoining by Escherichia coli DNA topoisomerase I","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.116056_bib43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jmb.2009.08.064","article-title":"Deciphering the distinct role for the metal coordination motif in the catalytic activity of Mycobacterium smegmatis topoisomerase I","volume":"393","author":"Bhat","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0022-2836(85)90075-0","article-title":"Bacterial DNA topoisomerase I can relax positively supercoiled DNA containing a single-stranded loop","volume":"185","author":"Kirkegaard","year":"1985","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib45","doi-asserted-by":"crossref","first-page":"13366","DOI":"10.1016\/S0021-9258(18)37713-5","article-title":"Identification of a potent decatenating enzyme from Escherichia coli","volume":"263","author":"DiGate","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib46","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1073\/pnas.93.8.3653","article-title":"Human TOP3: a single-copy gene encoding DNA topoisomerase III","volume":"93","author":"Hanai","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.116056_bib47","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1074\/jbc.275.3.1533","article-title":"Cloning and characterization of DrosophilaTopoisomerase III\u03b2: relaxation of Hypernegatively supercoiled DNA* 210","volume":"275","author":"Wilson","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib48","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0021-9258(17)42140-5","article-title":"Decatenating activity of Escherichia coli DNA gyrase and topoisomerases I and III during oriC and pBR322 DNA replication in vitro","volume":"269","author":"Hiasa","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib49","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1073\/pnas.95.3.1010","article-title":"Mammalian DNA topoisomerase III\u03b1 is essential in early embryogenesis","volume":"95","author":"Li","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.116056_bib50","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1006\/jmbi.1993.1474","article-title":"Crystallization of a 67 kDa fragment of Escherichia coli DNA topoisomerase I","volume":"232","author":"Lima","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/364735a0","article-title":"DNA topoisomerase V is a relative of eukaryotic topoisomerase I from a hyperthermophilic prokaryote","volume":"364","author":"Slesarev","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116056_bib52","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/S0021-9258(17)41862-X","article-title":"Purification and characterization of DNA topoisomerase V. An enzyme from the hyperthermophilic prokaryote Methanopyrus kandleri that resembles eukaryotic topoisomerase I","volume":"269","author":"Slesarev","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BJ20071286","article-title":"An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme","volume":"409","author":"Roy","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2023.116056_bib54","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.279.5356.1504","article-title":"Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA","volume":"279","author":"Redinbo","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.116056_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/expr.1998.4362","article-title":"Plasmodium falciparum: stage-related expression of topoisomerase I","volume":"91","author":"Tosh","year":"1999","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.116056_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00412-005-0345-5","article-title":"Human DNA topoisomerase I: relaxation, roles, and damage control","volume":"114","author":"Leppard","year":"2005","journal-title":"Chromosoma"},{"key":"10.1016\/j.ejmech.2023.116056_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.ejmech.2023.116056_bib58","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1093\/nar\/gkab270","article-title":"What makes a type IIA topoisomerase a gyrase or a Topo IV?","volume":"49","author":"Hirsch","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-018-2800-1","article-title":"Checks and balances? DNA replication and the cell cycle in Plasmodium","volume":"11","author":"Matthews","year":"2018","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2023.116056_bib60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10409239109114072","article-title":"DNA gyrase: structure and function","volume":"26","author":"Reece","year":"1991","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib61","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/351624a0","article-title":"Crystal structure of an N-terminal fragment of the DNA gyrase B protein","volume":"351","author":"Wigley","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116056_bib62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0968-0004(99)01503-0","article-title":"GHKL, an emergent ATPase\/kinase superfamily","volume":"25","author":"Dutta","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2023.116056_bib63","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature06396","article-title":"Structural basis for gate-DNA recognition and bending by type IIA topoisomerases","volume":"450","author":"Dong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116056_bib64","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1101\/gad.1367206","article-title":"A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1\/securin","volume":"20","author":"Andrews","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2023.116056_bib65","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.0510363103","article-title":"Evidence on the chromosomal location of centromeric DNA in Plasmodium falciparum from etoposide-mediated topoisomerase-II cleavage","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejmech.2023.116056_bib66","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijpara.2020.11.004","article-title":"Replication and partitioning of the apicoplast genome of Toxoplasma gondii is linked to the cell cycle and requires DNA polymerase and gyrase","volume":"51","author":"Martins-Duarte \u00c9","year":"2021","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2023.116056_bib67","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1073\/pnas.0400836101","article-title":"Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria","volume":"101","author":"Wall","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.116056_bib68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molbiopara.2007.04.001","article-title":"Nuclear gyrB encodes a functional subunit of the Plasmodium falciparum gyrase that is involved in apicoplast DNA replication","volume":"154","author":"Ram","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.116056_bib69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/pro.4217","article-title":"Role of unique loops in oligomerization and ATPase function of Plasmodium falciparum gyrase B","volume":"31","author":"Purushothaman","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2023.116056_bib70","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.drudis.2016.11.006","article-title":"DNA topoisomerase I and DNA gyrase as targets for TB therapy","volume":"22","author":"Nagaraja","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.116056_bib71","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/386414a0","article-title":"An atypical topoisomerase II from Archaea with implications for meiotic recombination","volume":"386","author":"Bergerat","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116056_bib72","doi-asserted-by":"crossref","first-page":"11274","DOI":"10.1073\/pnas.92.24.11274","article-title":"Covalent protein-DNA complexes at the 5'strand termini of meiosis-specific double-strand breaks in yeast","volume":"92","author":"Keeney","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.116056_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-5521(03)00027-9","article-title":"Emerging roles for plant topoisomerase VI","volume":"10","author":"Corbett","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib74","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0092-8674(03)01023-7","article-title":"Plasmodium biology: genomic gleanings","volume":"115","author":"Aravind","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.116056_bib75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/07352680490452816","article-title":"Plant DNA topoisomerases: structure, function, and cellular roles in plant development","volume":"23","author":"Singh","year":"2004","journal-title":"Crit. Rev. Plant Sci."},{"key":"10.1016\/j.ejmech.2023.116056_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00563-18","article-title":"Topoisomerase III acts at the replication fork to remove precatenanes","volume":"201","author":"Lee","year":"2019","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejmech.2023.116056_bib77","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1093\/nar\/27.20.4050","article-title":"Topoisomerase III is essential for accurate nuclear division in Schizosaccharomyces pombe","volume":"27","author":"Goodwin","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib78","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1186\/s12885-019-6371-0","article-title":"Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study","volume":"19","author":"Tesauro","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2023.116056_bib79","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.116056_bib80","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0006-2952(97)00556-X","article-title":"Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum","volume":"55","author":"Bodley","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116056_bib81","first-page":"2350","article-title":"Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?","volume":"7","author":"Li","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib82","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/acs.biochem.1c00240","article-title":"Topoisomerase II poisons: converting essential enzymes into molecular scissors","volume":"60","author":"Vann","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.116056_bib83","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1021\/bi201159b","article-title":"Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions","volume":"51","author":"Ketron","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.116056_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00267-21","article-title":"Inhibitory compounds targeting Plasmodium falciparum gyrase B","volume":"65","author":"Pakosz","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.116056_bib85","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","article-title":"Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding","volume":"289","author":"Mustaev","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib86","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.116056_bib87","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1074\/jbc.M115.689554","article-title":"DNA gyrase is the target for the quinolone drug ciprofloxacin in Arabidopsis thaliana","volume":"291","author":"Evans-Roberts","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00586-21","article-title":"Properties of Plasmodium falciparum with a deleted apicoplast DNA gyrase","volume":"65","author":"Tan","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.116056_bib89","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1073\/pnas.73.12.4474","article-title":"Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase","volume":"73","author":"Gellert","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejmech.2023.116056_bib90","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1021\/bi00061a033","article-title":"The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs","volume":"32","author":"Ali","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.116056_bib91","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0966-842X(96)10085-8","article-title":"DNA gyrase as a drug target","volume":"5","author":"Maxwell","year":"1997","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2023.116056_bib92","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1021\/cb500476q","article-title":"Potent antimalarial activity of acriflavine in vitro and in vivo","volume":"9","author":"Dana","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib93","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1093\/nar\/gkl567","article-title":"Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol","volume":"34","author":"Corbett","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib94","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational approaches in preclinical studies on drug discovery and development","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib95","series-title":"Schr\u00f6dinger Release 2021-1: QikProp","author":"QikProp","year":"2020"},{"key":"10.1016\/j.ejmech.2023.116056_bib96","series-title":"Rational Designing of Peptide-Ligand Conjugates-Based Immunotherapy for the Treatment of Complicated Malaria","author":"Godara","year":"2022"},{"key":"10.1016\/j.ejmech.2023.116056_bib97","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s13205-022-03258-4","article-title":"Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach","volume":"12","author":"Singh","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.ejmech.2023.116056_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.05.184","article-title":"High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment","volume":"160","author":"Naik","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2023.116056_bib99","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1475-2875-7-197","article-title":"Heterologous expression of plasmodial proteins for structural studies and functional annotation","volume":"7","author":"Birkholtz","year":"2008","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2023.116056_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010595","article-title":"DNA replication dynamics during erythrocytic schizogony in the malaria parasites Plasmodium falciparum and Plasmodium knowlesi","volume":"18","author":"McDonald","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2023.116056_bib101","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/gb-2003-4-2-r9","article-title":"Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray","volume":"4","author":"Bozdech","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2023.116056_bib102","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nbt.2925","article-title":"Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system","volume":"32","author":"Ghorbal","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.116056_bib103","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/expr.1998.4362","article-title":"Plasmodium falciparum: stage-related expression of topoisomerase I","volume":"91","author":"Tosh","year":"1999","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.116056_bib104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-6851(97)00223-5","article-title":"Intraerythrocytic expression of topoisomerase II from Plasmodium falciparum is developmentally regulated","volume":"92","author":"Cheesman","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.116056_bib105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00436-008-1036-y","article-title":"Ribozyme cleavage of Plasmodium falciparum gyrase A gene transcript affects the parasite growth","volume":"103","author":"Ahmed","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2023.116056_bib106","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/854626","article-title":"Peptide Inhibition of Topoisomerase IB from <i>Plasmodium falciparum<\/i&gt","volume":"2011","author":"Roy","year":"2011","journal-title":"Molecular Biology International"},{"key":"10.1016\/j.ejmech.2023.116056_bib107","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijpharm.2011.01.048","article-title":"Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II","volume":"416","author":"Bruxel","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejmech.2023.116056_bib108","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bcp.2015.03.018","article-title":"Targeting the gyrase of Plasmodium falciparum with topoisomerase poisons","volume":"95","author":"Tang Girdwood","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116056_bib109","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00025-15","article-title":"Radicicol-mediated inhibition of topoisomerase VIB-via activity of the human malaria parasite Plasmodium falciparum","volume":"1","author":"Chalapareddy","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.ejmech.2023.116056_bib110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.exppara.2016.03.008","article-title":"Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA nanoparticle against malaria topoisomerase II","volume":"164","author":"Attasart","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.116056_bib111","article-title":"Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium falciparum and P. Vivax","volume":"64","author":"Ferreira","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.116056_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115551","article-title":"In vitro dual activity of Aloe marlothii roots and its chemical constituents against Plasmodium falciparum asexual and sexual stage parasites","volume":"297","author":"Mianda","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2023.116056_bib113","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/14756366.2020.1821676","article-title":"DNA topoisomerases as molecular targets for anticancer drugs","volume":"35","author":"Buzun","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112326","article-title":"Recent advances in DNA gyrase-targeted antimicrobial agents","volume":"199","author":"Dighe","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116056_bib115","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.bmc.2018.05.016","article-title":"Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective","volume":"26","author":"Ponnusamy","year":"2018","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T14:48:01Z","timestamp":1736866081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423010231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":115,"alternative-id":["S0223523423010231"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116056","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmodium falciparum topoisomerases: Emerging targets for anti-malarial therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116056"}}